+44 7971 853 043


Cornwall, TR3 6QA, United Kingdom

About Us

About Altarnum 

Altarnum Consulting Limited was founded in 2010 to address the healthcare industry’s need for timely, insightful market access research and consulting in high-growth emerging markets.

Focusing on markets where pricing and market access is a  key strategic consideration, we can help companies to navigate the local market stakeholder environment in order to deliver long-term success for their innovative products.

Our virtual network of in-country partners enables us to go direct to the key players in HTA bodies, Health Ministries, private payer organizations and opinion-leading clinicians.

We believe our approach removes intermediaries, cuts project overheads, shortens research timelines and delivers truly actionable local insights.

Altarnum founder Ben Shankland has expertise in payer landscaping, directional pricing for novel products, analysing health economic access challenges and creating innovative patient access schemes in emerging markets. He has worked throughout his career to design workable local solutions that successfully and ethically integrate with the client’s global vision for emerging markets success.

Director Profile 

Altarnum founder Ben Shankland has 15 years’ experience in emerging markets, developing solutions for innovator companies in therapeutic areas including diabetes, cancer, lysosomal storage disorders, respiratory disease and infectious disease. He has worked for many large and small healthcare and pharmaceutical companies.

Ben was previously Lead Consultant (Emerging Markets) at Double Helix Consulting in London (now McCann Health). Originally a linguist, Ben has a Master’s Degree in Portuguese and Spanish from Oxford University, UK, and has published a number of market access research studies at various stages of his career. Ben founded Altarnum Consulting in early 2010.


Specialising in emerging markets, our mission is Connecting healthcare companies and decision makers for emerging markets.


Latest Assignments

KOL expectations for a novel cancer therapy
Global Pharmaceutical Client

Payer research in a vaccine for Japan and emerging markets in Latin America
Global Pharmaceutical Client

© Altarnum Consulting.  All rights reserved. View our privacy policy.  Registered in England under the Companies Act, No. 07507546